These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 822407)

  • 1. Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine.
    Loew DM; Jaton AL; Vigouret JM
    Postgrad Med J; 1976; 52suppl 1():40-46. PubMed ID: 822407
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.
    Vigouret JM; Bürki HR; Jaton AL; Züger PE; Loew DM
    Pharmacology; 1978; 16 Suppl 1():156-73. PubMed ID: 565520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropharmacological studies on hydergine.
    Depoortere H; Loew DM; Vigouret JM
    Triangle; 1975; 14(2):73-9. PubMed ID: 812222
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the central effects of ergot alkaloids by means of electroencephalography.
    Longo VG; Loizzo A
    Pharmacology; 1978; 16 Suppl 1():189-92. PubMed ID: 643900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropharmacology of bromocriptine and dihydroergotoxine (hydergine).
    Loew DM; Vigouret JM; Jaton A
    Adv Biochem Psychopharmacol; 1980; 23():63-74. PubMed ID: 6104915
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in the rat electrocorticogram following administration of two dihydrogenated ergot derivatives.
    Carruthers-Jones DI; Depoortere H; Loew DM
    Gerontology; 1978; 24 Suppl 1():23-33. PubMed ID: 412729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological aspects of dihydrogenated ergot alkaloids in experimental brain research.
    Meier-Ruge W; Emmenegger H; Enz A; Gygax P; Iwangoff P; Wiernsperger N
    Pharmacology; 1978; 16 Suppl 1():45-62. PubMed ID: 205890
    [No Abstract]   [Full Text] [Related]  

  • 8. Electroencephalogram and ergot alkaloids.
    Venn RD
    Postgrad Med J; 1976; 52suppl 1():55-6. PubMed ID: 822408
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of hydergine on the enzymes involved in cAMP turonver in the brain.
    Enz A; Iwangoff P; Markstein R; Wagner H
    Triangle; 1975; 14(2):90-2. PubMed ID: 173058
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings].
    Jaton AL; Loew DM; Vigouret JM
    Br J Pharmacol; 1978 Mar; 62(3):395P. PubMed ID: 565235
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Acta Endocrinol Suppl (Copenh); 1978; 216():27-56. PubMed ID: 347864
    [No Abstract]   [Full Text] [Related]  

  • 12. Central monoamine synapses as sites of action for ergot drugs.
    Fuxe K; Ogren SO; Agnati LF; Andersson K; Hall H; Köhler C; Fredholm B
    Adv Biochem Psychopharmacol; 1980; 23():41-62. PubMed ID: 6104914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases.
    Trabucchi M; Andreoli VM; Frattola L; Spano PF
    Adv Biochem Psychopharmacol; 1977; 16():661-5. PubMed ID: 196497
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptin and methylergometrine: pharmacological approach of the mechanism of their central effects.
    Puech AJ; Simon P; Chermat R; Boissier JR
    Pharmacol Res Commun; 1977 Mar; 9(3):299-306. PubMed ID: 577309
    [No Abstract]   [Full Text] [Related]  

  • 15. On the pharmacology of the ergot alkaloid elymoclavine.
    Petkov V; Georgiev V; Roussinov K; Grigorov I; Slokoska L; Angelova M; Lazarova M; Getova D; Todorov S; Radomirov R
    Biomed Biochim Acta; 1984; 43(11):1305-16. PubMed ID: 6442580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine and hydergine: a comparison on striatal or hypothalamic adenylate cyclase activity.
    Portaleone P
    Pharmacology; 1978; 16 Suppl 1():207-9. PubMed ID: 643903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trials on the suspension of ovulation in women by the use of anti-sympathotonic substances of the ergotamine group, as well as by other substances of the chlorpromazine and meprobamate type].
    Giarola A; Agostini G; Campanelli D
    Gynecol Prat; 1970; 21(5):397-402. PubMed ID: 4995898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [USE OF THE ERGOT ALKALOID PREPARATION, HYDERGINE, IN SURGERY].
    WATANUKI T; ISHIZUKA T; MOCHIZUKI N
    Rinsho Geka; 1964 May; 19():694-9. PubMed ID: 14148895
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of dihydroergotoxine, bromocriptine, and ergotamine on penile erection in Wistar rats.
    Radosavljevic M; Pajovic B; Radunovic M; Radojevic N; Bjelogrlic B
    J Androl; 2012; 33(5):866-71. PubMed ID: 22441761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotyped responses of rats to two 2-halogenoergolines: 2-bromo-alpha-ergocryptine and lergotrile.
    Bergmann F
    Isr J Med Sci; 1982 Jan; 18(1):177-82. PubMed ID: 6121772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.